Lambert et al., 1995 - Google Patents
Reprocessing of microcrystalline cellulose spheres with high drug concentrationsLambert et al., 1995
- Document ID
- 477284633405092377
- Author
- Lambert S
- Reilly W
- Schwartz J
- Publication year
- Publication venue
- Drug development and industrial pharmacy
External Links
Snippet
Spherical dosage forms have been reported to be an efficient and effective method for delivering drugs into the body and controlling their dissolution rate. Substantial work has been conducted in these laboratories to delineate the role of microcrystalline cellulose in the …
- 229920000168 Microcrystalline cellulose 0 title abstract description 19
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5688510A (en) | Process for producing stable medicinal composition, and pharmaceutical preparation | |
| DK175306B1 (en) | Process for preparing a pharmaceutical granule | |
| US2793979A (en) | Method of making a sustained release pharmaceutical tablet and product of the method | |
| US5456921A (en) | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds | |
| US3133863A (en) | Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums | |
| US6399096B1 (en) | Pharmaceutical formulation | |
| DE69434640T2 (en) | Heterodisperse hydrogel systems for the sustained release of insoluble drugs | |
| Sprockel et al. | A melt-extrusion process for manufacturing matrix drug delivery systems | |
| US5474989A (en) | Drug composition | |
| WO1995022319A1 (en) | Process for preparing fine particle pharmaceutical formulations | |
| BRPI0608609A2 (en) | extrusion process for preparing compositions with poorly compressible therapeutic compounds | |
| Erkoboni | Extrusion-spheronization as a granulation technique | |
| KR880010757A (en) | Pharmaceutical tablets, pharmaceutical granules and manufacturing method thereof | |
| US4267138A (en) | Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients | |
| WO1995005809A1 (en) | Gastric remaining preparation, swollen molding, and production process | |
| Zhang et al. | Effect of spheronization technique on drug release from uncoated beads | |
| Funck et al. | Binder effectiveness for beads with high drug levels | |
| Lambert et al. | Reprocessing of microcrystalline cellulose spheres with high drug concentrations | |
| CN102526007B (en) | Florfenicol taste masking preparation and preparation method for same | |
| Akhgari et al. | Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization | |
| JP3981134B2 (en) | Method for producing coated preparation with improved unpleasant taste | |
| Ross et al. | Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers | |
| KR100267525B1 (en) | Cytarabine ocfosfate hard capsule | |
| JP2000034224A (en) | Sustained-release tablet, additive composition for the tablet, and their production | |
| JPH04300821A (en) | Coated pharmaceutical preparation |